Changes of sodium and ATP affinities of renal Na,K-ATPase during and after nitric oxide-deficient hypertension

Physiological Research

Volumn 51, Issue 5, 2002, Pages 475-482

  Vrbjar, N ^b   Javorkova V ^b   Pechanova O ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b NONE

Author keywords

Hypertension; Kidney; L NAME; Nitric oxide; Sodium pump

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME KINETICS; ENZYME SUBSTRATE; HYPERTENSION; KIDNEY CELL; MALE; MICHAELIS CONSTANT; NONHUMAN; RAT; SYSTOLIC BLOOD PRESSURE;

ADENOSINE TRIPHOSPHATE; ANIMALS; BLOOD PRESSURE; CELL MEMBRANE; ENZYME INHIBITORS; HYPERTENSION, RENAL; KIDNEY; MALE; NA(+)-K(+)-EXCHANGING ATPASE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RATS; RATS, INBRED WKY; SODIUM;

EID: 12244253705     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. BABÁL P, PECHÁŇOVÁ O, BERNÁTOVÁ I: Long-term administration of D-NAME induces hemodynamic and structural changes in the cardiovascular system. Physiol Res 49: 47-54, 2000.
2. BABÁL P, PECHÁŇOVÁ O, BERNÁTOVÁ I: Morphological changes of cardiovascular system and their prevention in chronic NO-deficient hypertension in rat. Physiol Res. 50: P35, 2001.
3. BAYLIS C, MITRUKA B, DENG A: Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 90: 278-281, 1992.
4. BERNÁTOVÁ I, PECHÁŇOVÁ O, ŠIMKO F: Captopril prevents NO-deficient hypertension and left ventricular hypertrophy without affecting nitric oxide synthase activity in rats. Physiol Res 45: 311-316, 1996.
5. BERNÁTOVÁ I, PECHÁŇOVÁ O, ŠIMKO F: Effects of captopril in L-NAME-induced hypertension on the rat myocardium, aorta, brain and kidney. Exp Physiol 84: 1095-1105, 1999.
6. BREDT DS, SNYDER SH: Isolation of nitric oxide synthase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 87: 682-685, 1990.
7. +-ATPase by nitric oxide in mouse proximal tubule epithelial cells. J Clin Invest 95: 2083-2088, 1995.
8. HALČÁK L, PECHÁŇOVÁ O, ŽIGOVÁ Z, KLEMOVÁ L, NOVACKÝ M, BERNÁTOVÁ I: Inhibition of NO synthase activity in nervous tissue leads to decreased motor activity in the rat. Physiol Res 49: 143-149, 2000.
9. IGNARRO LJ, BUGA GM, WOOD KS, BYNS RE, CHAUDHURI G: Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84: 9265-9269, 1987.
10. JELICKS LA, GUPTA RK: Nuclear magnetic resonance measurement of intracellular sodium in the perfused normotensive and spontaneously hypertensive rat heart. Am J Hypertens 7: 429-435, 1994.
11. +)-ATPase: III. Purification from the outer medulla of mammalian kidney after selective removal of membrane components by sodium dodecylsulphate. Biochim Biophys Acta 356: 36-52, 1974.
12. 2+ binding and energy transduction in Na,K-ATPase. Biochim Biophys Acta 1505: 57-74, 2001.
13. KHAN MT, FURCHGOTT RF: Additional evidence that endothelium-derived relaxing factor is nitric oxide. In: Pharmacology, RAND MJ, RAPER C (eds), Elsevier, Amsterdam, 1987, pp 341-344.
14. +-ATPase in opossum kidney cells. Am J Physiol 277: F859-F865, 1999.
15. LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ: Protein measurement with the folin phenol reagent. J Biol Chem. 193: 265-275, 1951.
16. MAJID DS, NAVAR LG: Nitric oxide in the mediation of pressure natriuresis. Clin Exp Pharmacol Physiol 24: 595-599, 1997.
17. MANDARIM-DE-LACERDA CA, PEREIRA LMM: Renal cortical remodelling by NO blockers in rats is prevented by ACE inhibitor and calcium channel blocker. J Cell Mol Med 5: 276-283, 2001.
18. +-induced lethal arrhythmias. Physiol Res 50: P39, 2001.
19. OKRUHLICOVÁ L', TRIBULOVÁ N, BERNÁTOVÁ I, PECHÁŇOVÁ O: Induction of angiogenesis in nitric oxide-deficient rat heart. Physiol Res 49: 71-76, 2000.
20. PALMER RM, FERRIGE AG, MONCADA S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-526,1987.
21. PECHÁŇOVÁ O, BERNÁTOVÁ I: Effect of long-term NO synthase inhibition on cyclic nucleotide content in rat tissues. Physiol Res 45: 305-309, 1996.
22. PECHÁŇOVÁ O, BERNÁTOVÁ I: Effect of captopril on cyclic nucleotide concentrations during long-term NO synthase inhibition. Physiol Res 49: 55-63, 2000.
23. TAUSSKY HH, SHORR EE: A microcolorimetric method for the determination of inorganic phosphorus. J Biol Chem 202: 675-685, 1953.
24. TRIBULOVÁ N, OKRUHLICOVÁ U, BERNÁTOVÁ I, PECHÁŇOVÁ O: Chronic impairment of nitric oxide production results in histochemical and subcellular alterations of the rat heart. Physiol Res 49: 77-88, 2000.
25. VRBJAR N, BERNÁTOVÁ I, PECHÁŇOVÁ O: Changes of sodium and ATP affinities of the cardiac (Na,K)-ATPase during and after nitric oxide deficient hypertension. Mol Cell Biochem 202: 141-147, 1999.
26. ZHANG YB, MAGYAR CE, HOLSTEIN-RATHLOU NH, McDONOUGH AA: The cytochrome P-450 inhibitor cobalt chloride prevents inhibition of renal Na,K-ATPase and redistribution of apical NHE-3 during acute hypertension. J Am Soc Nephrol 9: 531-537, 1998.